Cargando…
M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression
Background: Ovarian cancer (OC) is the gynecologic malignant tumor with high mortality. Accumulating evidence indicates that M2-like tumor-associated macrophages (TAMs) can secret EGF to participate in ovarian cancer growth, migration, and metastasis. An EGF-downregulated lncRNA, LIMT (lncRNA inhibi...
Autores principales: | Zeng, Xiang-Yang, Xie, Hui, Yuan, Jing, Jiang, Xiao-Yan, Yong, Jia-Hui, Zeng, Da, Dou, Ying-Yu, Xiao, Song-Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606001/ https://www.ncbi.nlm.nih.gov/pubmed/31062668 http://dx.doi.org/10.1080/15384047.2018.1564567 |
Ejemplares similares
-
LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer
por: Sas‐Chen, Aldema, et al.
Publicado: (2016) -
The long non-coding RNA LIMT inhibits metastasis of hepatocellular carcinoma and is suppressed by EGF signaling
por: Hu, Yu, et al.
Publicado: (2022) -
LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells: LIMT contributes to sorafenib chemoresistance in HCC
por: Sun, Jing, et al.
Publicado: (2021) -
lncRNA ABHD11‐AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2
por: Zeng, Xiang‐Yang, et al.
Publicado: (2019) -
LIV-1 Promotes Prostate Cancer Epithelial-to-Mesenchymal Transition and Metastasis through HB-EGF Shedding and EGFR-Mediated ERK Signaling
por: Lue, Hui-Wen, et al.
Publicado: (2011)